Literature DB >> 34021047

UBX Domain Protein 6 Positively Regulates JAK-STAT1/2 Signaling.

Harshada Ketkar1,2, Andrew G Harrison1, Vincent R Graziano1, Tingting Geng1, Long Yang3, Anthony T Vella1, Penghua Wang4,2.   

Abstract

Type I/III IFNs induce expression of hundreds of IFN-stimulated genes through the JAK/STAT pathway to combat viral infections. Although JAK/STAT signaling is seemingly straightforward, it is nevertheless subjected to complex cellular regulation. In this study, we show that an ubiquitination regulatory X (UBX) domain-containing protein, UBXN6, positively regulates JAK-STAT1/2 signaling. Overexpression of UBXN6 enhanced type I/III IFNs-induced expression of IFN-stimulated genes, whereas deletion of UBXN6 inhibited their expression. RNA viral replication was increased in human UBXN6-deficient cells, accompanied by a reduction in both type I/III IFN expression, when compared with UBXN6-sufficient cells. Mechanistically, UBXN6 interacted with tyrosine kinase 2 (TYK2) and inhibited IFN-β-induced degradation of both TYK2 and type I IFNR. These results suggest that UBXN6 maintains normal JAK-STAT1/2 signaling by stabilizing key signaling components during viral infection.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34021047      PMCID: PMC8164993          DOI: 10.4049/jimmunol.1901337

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  51 in total

Review 1.  Regulation of cytokine signaling pathways by PIAS proteins.

Authors:  Ke Shuai
Journal:  Cell Res       Date:  2006-02       Impact factor: 25.617

2.  Ubxd1 is a novel co-factor of the human p97 ATPase.

Authors:  Louise Madsen; Katrine M Andersen; Søren Prag; Torben Moos; Colin A Semple; Michael Seeger; Rasmus Hartmann-Petersen
Journal:  Int J Biochem Cell Biol       Date:  2008-07-05       Impact factor: 5.085

3.  Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription.

Authors:  K A Mowen; J Tang; W Zhu; B T Schurter; K Shuai; H R Herschman; M David
Journal:  Cell       Date:  2001-03-09       Impact factor: 41.582

Review 4.  Role of protein arginine methyltransferase 5 in human cancers.

Authors:  Wendi Xiao; Xiaoqing Chen; Lisa Liu; Yuansen Shu; Min Zhang; Yucheng Zhong
Journal:  Biomed Pharmacother       Date:  2019-03-20       Impact factor: 6.529

5.  STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.

Authors:  Stuart T Perry; Michael D Buck; Steven M Lada; Christian Schindler; Sujan Shresta
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

6.  UBXD1 is a VCP-interacting protein that is involved in ER-associated degradation.

Authors:  Masami Nagahama; Machi Ohnishi; Yumiko Kawate; Takayuki Matsui; Hitomi Miyake; Keizo Yuasa; Katsuko Tani; Mitsuo Tagaya; Akihiko Tsuji
Journal:  Biochem Biophys Res Commun       Date:  2009-03-09       Impact factor: 3.575

Review 7.  RIG-I in RNA virus recognition.

Authors:  Alison M Kell; Michael Gale
Journal:  Virology       Date:  2015-03-05       Impact factor: 3.616

8.  Multiple UBXN family members inhibit retrovirus and lentivirus production and canonical NFκΒ signaling by stabilizing IκBα.

Authors:  Yani Hu; Kaitlin O'Boyle; Jim Auer; Sagar Raju; Fuping You; Penghua Wang; Erol Fikrig; Richard E Sutton
Journal:  PLoS Pathog       Date:  2017-02-02       Impact factor: 6.823

9.  Ubiquitination of the N-terminal region of caveolin-1 regulates endosomal sorting by the VCP/p97 AAA-ATPase.

Authors:  Philipp Kirchner; Monika Bug; Hemmo Meyer
Journal:  J Biol Chem       Date:  2013-01-19       Impact factor: 5.157

Review 10.  UBXD Proteins: A Family of Proteins with Diverse Functions in Cancer.

Authors:  Khosrow Rezvani
Journal:  Int J Mol Sci       Date:  2016-10-14       Impact factor: 5.923

View more
  1 in total

1.  Prioritisation of Candidate Genes Underpinning COVID-19 Host Genetic Traits Based on High-Resolution 3D Chromosomal Topology.

Authors:  Michiel J Thiecke; Emma J Yang; Oliver S Burren; Helen Ray-Jones; Mikhail Spivakov
Journal:  Front Genet       Date:  2021-10-25       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.